BIO vs MTX · rev $651.0M vs P/E 15, rev $1.10B
BIO (BIO) versus Minerals Technologies Inc (MTX) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Minerals Technologies Inc (MTX) is a specialty chemicals company listed on NYSE.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported MTX revenue for 2026-07-05 was $1.10B. Net income was -$147.4M. MTX currently screens at market cap $2.39B and trailing P/E 15.1.
BIO currently screens at market cap $0. MTX currently screens at market cap $2.39B and trailing P/E 15.1.
Not investment advice. Open the BIO and MTX stock pages for the full models.
Not investment advice.